首页> 外文会议>European Association for Clinical Pharmacology and Therapeutics >Pharmacokinetlc study of ropivacaine for labor analgesia with intermittent intrapartum administration and top-up expulsion dose
【24h】

Pharmacokinetlc study of ropivacaine for labor analgesia with intermittent intrapartum administration and top-up expulsion dose

机译:具有间歇性脑内施用和充值驱逐剂量的分娩镇痛罗哌卡因的药曲线研究

获取原文

摘要

The aim of the study was to measure and analyzed the concentration of free ropivacaine in maternal plasma during labor with intermittent intrapartum administration of 0.2% ropivacaine. Our study showed a significant decrease of ropivacaine doses from 17.6 +- 0.49 mg to 13.6 +- 0.7 mg with no modification in comfort interval after each injection. Concentration of free ropivacaine was significantly higher after second and third epidural doses. The highest concentration was determined 25 min after expulsion. Conclusions: A small decrease in ropivacaine doses during progress of labor does not decrease the maternal plasma concentration. Top-up doses do not increase the expulsion concentration. The highest concentration of ropivacaine was recorded 25 min after top-up doses and constant decrease in postpartum study interval.
机译:该研究的目的是测量并分析在劳动期间母体血浆中自由Ropivacaine的浓度,间歇性牛肝菌饲料施用0.2%Ropivacaine。我们的研究表明,Ropivacaine剂量的显着降低,13.6±0.49mg至13.6±0.7mg,每次注射后没有舒适间隔内没有修饰。二次和第三个硬膜外剂量后,自由Ropivacaine的浓度明显高。排出后25分钟测定最高浓度。结论:在劳动过程中罗哌港剂量的小减少不会降低母体血浆浓度。充值剂量不会增加驱逐浓度。在瓶盖剂量和产后研究间隔的持续减少后,罗哌卡因的最高浓度记录了25分钟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号